To view the PDF file, sign up for a MySharenet subscription.
Back to DCP SENS
DIS-CHEM:  3,260   +105 (+3.33%)  02/05/2025 19:00

DIS-CHEM PHARMACIES LIMITED - Dealing in Securities by an Associate of a Prescribed Officer

Release Date: 02/05/2025 17:00
Code(s): DCP     PDF:  
Wrap Text
Dealing in Securities by an Associate of a Prescribed Officer

Dis-Chem Pharmacies Limited
(Incorporated in the Republic of South Africa)
(Registration number 2005/009766/06)
JSE securities code: DCP
ISIN: ZAE000227831
("Dis-Chem" or "the Company")

DEALING IN SECURITIES BY AN ASSOCIATE OF A PRESCRIBED OFFICER


In compliance with sections 3.63 to 3.74 of the Listings Requirements of the JSE Limited ("JSE"), the
following information is disclosed:

Name of prescribed officer:      Brian Epstein
Name of associate:               Busdis Proprietary Limited
Class of securities:             Ordinary shares
Nature and extent of interest:   Indirect beneficial on-market disposal

Number of securities:            400 000
Price per security:              R38.00
Value of transaction:            R15 200 000
Date of transaction:             06 November 2024

Number of securities:            612 063
Average price per security:      R38.2912
Value of transaction:            R23 436 644.90
Date of transaction:             12 November 2024


Clearance for the above transactions was obtained in accordance with Dis-Chem's share dealings policy
however the transaction was not reported to the Company Secretary therefore the announcement is
delayed.

Nikki Lumley
Company Secretary
Midrand
02 May 2025
Sponsor
The Standard Bank of South Africa Limited

Date: 02-05-2025 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.